Peginterferon alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels
- 1 December 2004
- journal article
- clinical trial
- Published by Elsevier in Gastroenterology
- Vol. 127 (6), 1724-1732
- https://doi.org/10.1053/j.gastro.2004.09.050
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis CAnnals of Internal Medicine, 2004
- Outcomes of interferon and ribavirin treatment for chronic hepatitis C in patients with normal serum aminotransaminasesGut, 2003
- Prevalence of Liver Disease in a Population of Asymptomatic Persons with Hepatitis C Virus InfectionAnnals of Internal Medicine, 2002
- Treatment of patients with hepatitis C and normal serum aminotransferase levelsHepatology, 2002
- Predictive value of ALT levels for histologic findings in chronic hepatitis C: A European collaborative studyHepatology, 2002
- Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus InfectionNew England Journal of Medicine, 2002
- Interferon-Alpha in Combination with Ribavirin for the Treatment of Chronic Hepatitis C in Patients with Persistently Normal Aminotransferase LevelsDigestion, 2002
- Prospective study on anti-hepatitis C virus-positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNAHepatology, 2001
- Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trialThe Lancet, 2001
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995